Herb-drug pharmacokinetic interactions reviewed

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 12, 2010, Pages 1515-1538

  Tarirai, Clemence ^a   Viljoen, Alvaro M ^a   Hamman, Josias H ^a  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Absorption; Biotransformation; Distribution; Efflux transporter; Excretion; Herbdrug interaction; Pharmacokinetics

Indexed keywords

AMITRIPTYLINE; ANDROGRAPHIS PANICULATA EXTRACT; ANTIINFLAMMATORY AGENT; CISPLATIN; CURCUMA LONGA EXTRACT; CYCLOSPORIN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DIGOXIN; DOXORUBICIN; ECHINACEA ANGUSTIFLORA EXTRACT; FOENICULUM VULGARE EXTRACT; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GLYCOPROTEIN P; GLYCYRRHIZA GLABRA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; MIDAZOLAM; MULTIDRUG RESISTANCE PROTEIN 1; NIFEDIPINE; PHENYTOIN; PREGNANE X RECEPTOR; RHODAMINE 123; TACROLIMUS; TALINOLOL; UNINDEXED DRUG; VINBLASTINE; WARFARIN;

ALISMA ORIENTALIS; ARUNTII NOBILIS PERCARPIUM; BLACK PEPPER; CABBAGE; CASEA SIAMEN; CINNAMOMUM BURMANI; COMPLEX FORMATION; CRANBERRY; CROTON TIGLIUM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG TRANSFORMATION; DRUG UPTAKE; ELEUTHEROCOCCUS SENTICOSUS; ENZYME INDUCTION; ENZYME INHIBITION; EVODIA RUTAECARPA; FICUS CITRIFOLIA; GARLIC; GASTROINTESTINAL MOTILITY; GINGER; GINSENG; GRAPE; GRAPEFRUIT; HERB; HERB DRUG INTERACTION; HUMAN; HYDRASTIS; HYPERICUM PERFORATUM; HYPOXIS HEMEROCALLIDEA; LACTUCA TARAXACIFOLIA; LEMON; LIME (FRUIT); LINSEED; LOBELIA; MAGNOLIA GRANDIFLORA; MALUS DOMESTICA; MOMONDIA CHARANOFIA; MORINDA CITRIFOLIA; NEPHELIUM LAPPACEUM; NONHUMAN; OREGANO; PAUSINYSTALIA YOHIMBE; PEPPER; PEUCEDANUM PRAERUPTORUM; PHARMACODYNAMICS; PIPER CUBECA; PIPER LONGUM; PIPER METHYSTICUM; PUMMELO; PYLANTUS AMARUS; REVIEW; ROSEMARY; SABAL; SALVIA MILTIORRHIZA; SENNA; SILYBUM MARIANUM; SOLANUM LYCOPERSICUM; SOPHORA JAPONICA; SOUR ORANGE; STEMONA CURTISII; STRYCHNOS LIGUSTRINA; SUTHERLANDIA FRUTESCENS; SWEET ORANGE; TANGERINE; TEA; TRIDAX PROCUMBENS; UNCARIA TOMENTOSA; VALERIANA OFFICINALIS; ZANTHOXYLI FRUCTUS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL TRANSPORT; ENZYME INDUCTION; ENZYME INHIBITORS; GASTROINTESTINAL MOTILITY; HERB-DRUG INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; PHARMACEUTICAL PREPARATIONS; PLANT PREPARATIONS;

EID: 78649244514     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425255.2010.529129     Document Type: Review

References (195)

1. Schmidt B, Ribnicky DM, Poulev A, et al. A natural history of botanical therapeutics. Metab Clin Exp 2008;57: S3-9
2. Itokawa H, Morris-Natshke SL, Akiyama T, Lee KH. Plant-derived natural product research aimed at new drug discovery. J Nat Med 2008;62:263-80
3. Zhou S. Herbal medicine and drug interactions. Innovation 2006;6:44-5
4. World Health Organisation (WHO). General guidelines for methodologies on research and evaluation of traditional medicine. WHO, Geneva; 2000
5. Hamman JH, Tarirai C. Functional excipients. Int J Chem Biotechnol (Chem Today) 2006;24(5):57-62
6. Johnston SL. Herbal medications - harmless or harmful? S Afr J Anaesth Analg 2003;9:16-17
7. Mills E, Cooper C, Kanfer I. Traditional African medicine in the treatment of HIV: infection. Lancet 2005a; 5:465-7
8. Ingersoll RE. Herbaceuticals: an overview for counsellors. J Counsel Dev 2005;83:434-43
9. Colalto C. Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment. Pharmacol Res 2010;62:207-27 •• A detailed review that highlights the effects of selected commercially important herbal products on drug absorption.
10. Vermaak I, Hamman JH, Viljoen AM. High performance thin layer chromatography as a method to authenticate Hoodia gordonii raw material and products. SA J Bot 2010;76:119-24
11. Cass H. Herbs for the Nervous System: Ginkgo, Kava, Valerian, Passionflower. Semin Integrat Med 2004;2:82-8
12. Butterweck V, Derendorf H. Potential of pharmacokinetic profiling for detecting herbal interactions with drugs. Clin Pharmacokinet 2008;47:383-97
13. Lin JH, Lu AYH. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 1998;35:361-90
14. Lin JH. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug del Rev 2003;5:53-81
15. Gardiner P, Phillips R, Shaughnessy AF. Herbal and dietary supplement-drug interactions in patients with chronic illnesses. Am Fam Physician 2008;77:73-8
16. Li CG, Yang L, Zhou SF. Interactions between Chinese herbal medicines and drugs. Aust J Acupunct Chinese Med 2007;2:17-24
17. Williamson EM. Drug interactions between herbal and prescription medicines. Drug Safety 2003;26(15):1075-92
18. Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587-95
19. Sinxadi P, Blockman M. Possible herbal medicine-drug interactions in the postoperative period. Clin Pharmacol 2008;26:157-9
20. Manzi SF, Shanon M. Drug interactions - a review. Clin Pediatr Emerg Med 2005;6:93-102 • A detailed explanation of drug interaction mechanisms.
21. Yang XX, Hu ZP, Duan W, et al. Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm des 2006;12:4649-64
22. Tomlinson B, Hu M, Lee VWY. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? Mol Nutr Food Res 2008;52:799-809
23. Zhou S, Chan E, Lim LY, et al. Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr Drug Metab 2004;5(5):415-42
24. Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46:101-10
25. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36:57-104 •• A comprehensive review on P-gp modulated herb-drug interactions.
26. Farkas D, Greenblatt DJ. Influence of fruit juices on drug disposition; discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol 2008;4:381-93 • One of few studies indicating in vitro/in vivo correlations of herb-drug interactions.
27. Butterweck V, Zdrojewski I, Galloway C, et al. Toxicological and pharmacokinetic evaluation of concomitant intake of grapefruit juice and simvastatin in rats after repeated treatment over 28 days. Planta Med 2009;75:1196-202 • The first report on long-term effects of grape fruit juice on pharmacokinetics of simvastatin.
28. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 1997;25(11):1228-33
29. Zhou SF, Xue CC, Yu XQ, et al. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 2007;29(6):687-710
30. Food and Drug Administration (FDA). Guidance for industry. Drug interactions studies: study design, data analysis, and implications for dosing and labelling. Draft Guidance. Available from: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072101.pdf
31. Liu J, Brunner LJ. Chronic cyclosporine administration induces renal P-glycoprotein in rats. Eur J Pharmacol 2001;418:127-32
32. Jette L, Beaulieu E, Leclerc JM, Beliveau R. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am J Physiol 1996;270: F756-65
33. LeCluyse EL. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chem Biol Interact 2001;134:283-9
34. Moore LB, Goodwin B, Jones SA, et al. St John's Wort induces hepatic drug metabolism through activation of the pragnane X receptor. Proc Natl Acad Sci USA 2000;97:7500-02
35. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR co-ordinately regulates drug metabolism and efflux. Nat Med 2001;7:584-90
36. Geick A, Eichelbaum M, Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 2001;276:14581-7
37. Durr D, Stieger B, Kullak-Ublick GA, et al. St John's Wort induces intestinal P-gycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000;68:598-604
38. Ho YF, Haung OK, Hsueh WC, et al. Effects of St John's Wort extract on indinavir pharmacokinetics in rats: differentiation of intestinal and hepatic impacts. Life Sci 2009;85:296-302
39. Lundahl A, Hedeland M, Bondesson U, et al. The effect of St John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men. Eur J Pharm Sci 2009;36:433-43
40. Mills E, Foster BC, Van Heeswijk R, et al. Impact of African herbal medicines on antiretroviral metabolism. AIDS 2005;19:95-7
41. Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 2008;102:466-75
42. Breedveld P, Bijinen JB, Schellens JH. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci 2005;27:17-24
43. Varma MVS, Ashokraj Y, Dey CS, Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 2003;48:347-59
44. Zhang L, Strong JM, Qiu W, et al. Scientific perspective on drug transporters and their role in drug interactions. Mol Pharm 2006;3:62-9
45. Sadeque AJ, Wandel C, He H, et al. Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther 2000;68:231-7
46. Van Asperen J, Van Tellingen O, Beijnen JH. The role of mdr1a P-glycoprotein in the billiary and intestinal secretion of doxorubicin and vinblastine in mice. Drug Metab Dispos 2000;28:264-7
47. Okamura N, Hirai M, Tanigawara Y, et al. Digoxin-cyclosporin a interaction: modulation of multidrug transporter in kidney. J Pharmacol Exp Ther 1993;266:1614-19
48. Takano M, Yumoto R, Murakami T, Inui K. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 2006;109:137-61
49. Mandava N, Oberol RK, Minocha M, Mitra AK. Transporter targeted drug delivery. J Drug del Sci Technol 2010;20:89-99
50. Chan LM, Lowes S, Hirst BH. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 2004;21:25-51
51. Sun J, He Z, Cheng G, et al. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit 2004;10: RA5-14
52. Loo TW, Bartlett MC, Clarke DM. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding. J Biol Chem 2003;278:13603-6
53. Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sci 2006;78:2105-15 • One of few studies indicating in vitro/in vivo correlations of herb-drug interactions.
54. Salama NN, Scott KR, Eddington ND. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents. Int J Pharm 2004;273:135-47
55. Nowack R. Review article: cytochrome P450 enyzme, at John' Wort - and beyond! Nephrology 2003;13:337-47
56. Gutmann H, Poller B, Buter KB, et al. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression? Planta Med 2006;72(8):685-90
57. Brown I, Heyneke O, Brown D, et al. Impact of traditional medicinal plant extracts on antiretroviral drug absorption. J Ethnopharmacol 2008;119:588-92
58. Dasgupta A, Hovanetz M, Oslen M, et al. Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice. Arch Pathol Lab Med 2007;131:1094-8
59. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St John's wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethyl estradiol ovarian activity and breakthrough bleeding. Contraception 2005;71:402-8
60. Foster BC, Arnason JT, Briggs CJ. Natural health products and drug disposition. Annu Rev Pharmacol Toxicol 2005;45:203-26
61. Nair VD, Foster BC, Arnason JT, et al. In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato. Phytomedicine 2007;14:498-507
62. De Maart MM, Elhart GC, Huitema AD, et al. Drug interaction between antiretroviral drugs and comedicated agents. Clin Pharmacokinet 2003;42:223-82
63. Budzinski JW, Foster BC, Trudeau VL, et al. The interaction of selected phytochemical, HIV drugs, and commercial-source herbal teas and capsules with human cytochrome P450 3A4 and P-glycoprotein. Pharm Biol 2008;46:53-65
64. Hsiu SL, Hou YC, Wang YH, et al. Quercetin significantly decreased cyclosporine oral bioavailability in pigs and rats. Life Sci 2002;72:227-35
65. Nabekura T, Kamiyama S, Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-gylcoprotein function. Biochem Biophys Res Commun 2005;327:866-70
66. Juan H, Terhaag B, Cong Z, et al. Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol 2007;63:663-8
67. Tuntipopipat S, Judprasong K, Zeder C, et al. Chili, but not turmeric, inhibits iron absorption in young women from a iron-Fortified composite meal. J Nutr 2006;136:2970-4
68. Lim SK, Lim LY. Effects of citrus fruit juices on cytoxicity and drug transport pathways of Caco-2 cell monolayers. Int J Pharm 2006;302:42-50
69. Spahn-Langguth H, Langguth P. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci 2001;12:361-7 • Fundamental research to proof mechanism of herb-drug interaction.
70. Dresser GK, Bailey DG, Leake BF, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71:11-20
71. Huang SM, Lesko LJ. Drug-drug, drug dietary supplement, and drug-citrus fruit and other food interactions: What have we learned? J Clin Pharmacol 2004;44:559-69
72. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: effect on serum concentration of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 1998;64:477-83
73. Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and Seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci 2002;71:1149-60
74. Schwarz UI, Seemann D, Oertel R, et al. Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther 2005;77:291-301
75. Demeule M, Brossard M, Turcotte S, et al. Diallyl disulfide, a chemopreventive agent in garlic, induces multidrug resistance-associated protein 2 expression. Biochem Biophys Res Commun 2004;324:937-45
76. Munday R, Munday CM. Low doses of diallyl disulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferase in the gastrointestinal tract of the rat. Nutr Cancer 1999;34(1):42-8
77. Gurley BJ, Gardner SF, Hubbard MA, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005;22:525-39 ull;cal study to show herb-drug pharmacokinetic interactions.
78. Gallicano K, Foster B, Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003;55:199-202
79. Markowitz JS, DeVane CL, Chavin KD, et al. Effect of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther 2003;74:170-7
80. Jodoin J, Demeule M, Béliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 2002;1542:149-59
81. Lin LC, Wang MN, Tsai TH. Food-drug interaction of (-) - epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38. Chemioc-Biol Inter 2008;178:177-82
82. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004;76:428-40
83. Maitrejean M, Comte G, Barron D, et al. The flavanolignan Silybin and its hemisynthetic derivatives, a novel of potential modulators of P-glycoprotein. Bioorganic Med Chem Lett 2000;10:157-60
84. Gurley BJ, Barone GW, Williams DK, et al. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2007;35(2):240-5
85. Wu JW, Lin LC, Tsai TH. Drug-drug interactions of silymarin on the prospective of pharmacokinetics. J Ethnopharmacol 2009;121:185-93
86. Gazak R, Walterova D, Kren V. Silbin and silymarin - new and emerging applications in medicine. Curr Med Chem 2009;14:315-38
87. Srinder C, Goosen TC, Kent UM, et al. Slybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. Drug Metab Dispos 2004;32:587-94
88. Zhang S, Yang X, Morris ME. Comnined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharm Res 2004;21:1263-73 (Pubitemid 38954213)
89. Chang JC, Wu YT, Lee WC, et al. Herb-drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats. Chemico-Biol Inter 2009;182:227-32
90. Tamayo C, Diamond S. Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum mariunum [L.] Gaertn.). Integr Cancer Ther 2007;6(2):146-7
91. Lala LG, D'Mello PM, Naik SR. Pharmacokinetic and pharmacodynamic studies of interaction of "Tarikatu" with diclofenac sodium. J Ethnopharmacol 2004;91:277-80
92. Gurley BJ, Swain A, Hubbard MA, et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effect of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res 2008;52(7):755-63
93. Gurley BJ, Swain A, Barone GW, et al. Effect of Goldenseal (Hydrastis canadensis) and Kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Disp 2007;35(2):240-5
94. Kudolo GB, Wang W, Javors M, Blodgett J. The effect of the ingestion of Ginkgo biloba extract (EGb761) on the pharmacokinetics of metformin in non-diabetic and type-2 diabetic subjects - a double blind placebo-controlled, crossover study. Clin Nut 2006;25:606-16
95. Buchler M, Konig J, Brom M, et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-8
96. Ozvegy C, Litman T, Szakacs G, et al. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun 2001;285:111-17
97. Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003;22:7340-58
98. Cooray HC, Janvilisri T, Van Veen HW, et al. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun 2004;371:269-75
99. Bailey DG, Dresser GK, Leake BF, et al. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther 2007;81:495-502
100. Kobayashi D, Nozawa T, Imai K, et al. Involvement of human organic anion transporting polypeptide OATPB (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 2003;306:703-8
101. Wenzel U, Kuntz S, Daniel H. Flavonoids with epidermal growth factor receptor tyrosine kinase inhibitory activity stimulate PEPT1-mediated cefixime uptake into human intestinal epithelial cells. J Pharmacol Exp Ther 2001;299:351-7
102. Amabeoku GJ. Antidiarrhoeal activity of Geranium incanum Burm.f. (Geraniaceae) leaf aqueous extract in mice. J Ethnopharmacol 2009;123:190-3
103. Yamazaki T, Matsushita Y, Kawashima K, et al. Evaluation of the pharmacological activity of extracts from Amomi Semen on the gastrointestinal tracts. J Ethnopharmacol 2000;71:331-5
104. Lima ZP, de Cassia dos Santos R, Torres TU, et al. Byrsonima fagifolia: an intergrative study to validate the gastroprotective, healing, antidiarrheal, antimicrobial and mutagenic action. J Ethnopharmacol 2008;120:149-60
105. Wang X, Lan M, Wu HP, et al. Direct effect of croton oil on intestinal epithelial cells and colonic smooth muscle cells. World J Gastroenterol 2002;8:103-7
106. Wang X, Zhang FM, Liu ZX, et al. Effects of essential oil from Croton tiglium L. on intestinal transit time in mice. J Ethnopharmacol 2008;117:102-7
107. Wang X, Zhong YX, Lan M, et al. Screening and identification of proteins mediating senna induced gastrointestinal motility enhancement in mouse colon. World J Gastroenterol 2002;8:162-7
108. Fugh-Berman A. Herb-drug interactions. Lancet 2000;355:134-8
109. Han Y, Tan TCT, Lim L-Y. Effects of capsaicin on P-gp function and expression in Caco-2 cells. Biochem Pharmacol 2006;71:1727-34
110. Debreceni A, Abdel-Salam OME, Fingler M, et al. Capsaicin increases gastric emptying rate in healthy human subjects measured by C-labeled octanoic acid breath test. J Physiol Paris 1999;93:455-60
111. Limlomwongse L, Chaitauchawong C, Tongyai S. Effect of capsaicin on gastric acid secretion and mucosal blood flow in the rat. J Nutr 1979;109(5):773-7
112. Uduphille M. The effect of capsaicin on the small intestine absorption of glucose and alanine in the rat. Indian J Physiol Pharmacol 1993;37:59-62
113. Cruz L, Castaneda-Hernandez G, Navarrete A. Ingestion of chilli pepper (Capsicum annuum) reduces salicylate biovailability after oral aspirin administration in the rat. Can J Physiol Pharmacol 1999;77:441-6
114. Li Y, Matsuda H, Yoshikawa M. Effects of oleanolic acid glycosides on gastrointestinal transit and illeaus in mice. Biorg Medic Chem 1999;7:1201-5 (Pubitemid 29281624)
115. Sibaev A, Yuece B, Kelber O, et al. STW5 (Iberogast® its components modulate intestinal electrophysiology of mice. Phytomedicine 2006;13:80-9
116. Heinle H, Hagelauer D, Pascht U, et al. Intestinal spasmolytic effects of STW5 (Iberogast®) and its components. Phytomedicine 2006;13: SV75-9
117. Hohenester B, Ruhl A, Kelber O, Schemann M. The herbal preparation STW5 (Iberogast®) has potent and region-specific effects on gastric motility. Neurogastroenterol 2004;16:765-73
118. Chiesara E, Borghini R, Marabini L. Dietary fibre and drug interactions. Eur J Clin Nutr 1995;49(Suppl 3): S123-8
119. Van den Bout-van den Beukel CJ, Koopmans PP, Van der ven AJ, et al. Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents. Drug Metab Rev 2006;38:477-514
120. Yale SH, Glurich I. Analysis of the inhibitory potential of Ginkgo biloba, Echenacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med 2005;11:433-9
121. Markowitz JS, Donovan JL, Devane CL, et al. Multiple doses of saw palmetto (Serenoa repens) do not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 2003;74:536-42
122. Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Lif Sci 1996;59:1025-30
123. Edward DJ, Fitzmmons ME, Schuetz EG, et al. 6'7'-Dihydroxybergamottin in grapefruit and Seville orange juice: effects on cyclosporine disposition, etherocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999;65:237-44
124. Subehan, Usia T, Iwata H, et al. Mechansim-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicnal plants. J Ethnopharmcol 2006;105:449-55
125. Fang ZZ, Zhang YY, Ge GB, et al. Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 2010;69(2):193-9
126. Hidaka M, Fujita KI, Ogikubo T, et al. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug Metab Disp 2004;32:581-3
127. Kim H, Yoon YJ, Shon JH, et al. Inhibitory effects of fruit juices on CYP3A activity. Drug Metab Disp 2004;34:521-3
128. Anke J, Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with kava (Piper methysticum (forst. f.)). J Ethnopharmacol 2004;93:153-60
129. Singh YN. Potential for interaction of Kava and St John's wort with drugs. J Ethnopharmacol 2005;100:108-13
130. Freeman C, Spelman K. A critical evaluation of drug interactions with Echinacea spp. Mol Nutr Food Res 2008;52:789-98
131. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh and valerian on human cytochrome P450 1A2, 2D6, 2E1 and 3A4 phenotypes. Clin Pharmacol Ther 2005;77(5):415-26
132. Tang J, Sun J, Zhang Y, et al. Herb-drug interactions: effect of Ginkgo biloba extract on the pharmacokinetic of theophylline in rats. Food Chem Toxicol 2007;45:2441-5
133. Song M, Hang TJ, Zhang Z, Chen HY. Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat. Eur J Pharm Sci 2007;32:247-53
134. Wang X, Lee WYW, Or PMY, Yeung JHK. Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat. Phytomedicine 2010;17:203-11
135. Janetzky K, Morreale AP. Probable interactions between warfarin and ginseng. Am J Health Syst Pharm 1997;54:692-3
136. MacRae S. Elevated digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996;155:293-5
137. Lee J, Lee E, Kim D, et al. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol 2009;122:143-8
138. Wang C, Zhang JX, Shen XL, et al. Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate. Biochem Pharmacol 2004;68:843-55
139. Fong WF, Wang C, Zhu GY, et al. Reversal of multidrug resistance in cancer cells by Rhizoma alismatis extract. Phytomedicine 2007;14:160-5
140. Foster BC, Foster MS, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 2001;4(2):176-84
141. Macan H, Uykimpang R, Alconcel M, et al. Significance of garlic and its constituents in cancer and cardiovascular disease: aged garlic extract may be safe for patients on warfarin therapy. J Nutr 2006;136(Suppl 3): S793-5
142. Chien CF, Wu YT, Lee WC, et al. Herb-drug interaction of andrographics paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats. Chemic-Biol Inter 2010;184:458-65
143. Wells PS, Holbrook AM, Crowder NR, Hirsh J. Interactions of warfarin with drugs and foods. Ann Intern Med 1994;121:676-83
144. Jang EH, Choi JY, Park CS, et al. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats. J Pharm Pharmacol 2005;57(3):311-16
145. Donovan JL, Chavin KD, DeVane CL, et al. Green Tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32(9):906-8
146. Alemdaroglu NC, Dietz U, Wolffram S, et al. Influence of green tea and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid biovailability. Biopharm Drug Disp 2008;29(6):335-48
147. Chow H-H, Hakim IA, Vining DR, et al. Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 2006;15(12):2473-6
148. Bailey DG, Dresser GK, Blend JR. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther 2003;73:529-37
149. Egashira K, Ohtani H, Itoh S, et al. Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-gylcoprotein. Drug Metab Dispos 2004;32:828-33
150. Grenier J, Fradette C, Morelli G, et al. Pomelo juice, but not cranberry juice affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 2006;79:255-62
151. Xu J, Go ML, Lim LY. Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit and pummel. Pharm Res 2003;20:169-76
152. Mohri K, Uesawa Y. Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm Res 2001;18:177-82
153. Wagner D, Spahn-Langguth H, Hanfy A, et al. Intestinal drug efflux: formulation and food effects. Adv Drug del Rev 2001;50: S13-31
154. Ikegawa T, Ushigome F, Koyabu N, et al. Inhibition of P-glycoprotein by orange juice components polymethoxyflavones in adriamycin-resistant human myelogenous leukaemia (K562/ADM) cells. Cancer Lett 2000;160:21-8
155. Takanaga H, Ohnishi A, Yamada S, et al. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A. J Pharmacol Exper Ther 2000;293:230-6
156. Teodori E, Dei S, Scapecchi S, Gualtieri F. The medicinal chemistry of multidrug resistance (MDR) reversing drugs. II Farmaco 2002;57:385-415
157. Zou L, Harkey MR, Henderson GL. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 2002;71:1579-89
158. Guo LQ, Taniguchi M, Xiao YQ, et al. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A4 activity. Jpn J Pharmacol 2000;82:122-9
159. Gleaser H, Bailey DG, Dresser GK, et al. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther 2007;81(3):362-70
160. Rajnarayana K, Reddy MS, Krishma DR. Diosmin pretreatment affects biovailability of metronidazole. Eur J Clin Pharmacol 2003;58:803-7
161. Rajnarayana K, Venkatesham A, Krishna DR. Biovailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers. Drug Metabol Drug Interact 2007;22:165-74
162. Tian R, Koyabu N, Takanaga H, et al. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res 2002;19:802-9
163. Honda Y, Ushigome F, Koyabu N, et al. Effects of grapefruit juice and orange juice components on P-glycoprotein-and MRP2-mediated drug efflux. Br J Clin Pharmacol 2004;143:856-64
164. Lilja JJ, Huntti-Patinen L, Neuvonen PJ. Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol. Clin Pharmacol Ther 2004;75:184-90
165. Backman JT, Maenpaa J, Belle DJ, et al. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Clin Pharmacol Ther 2000;67:382-90
166. Zhang W, Tan TMC, Lim L-Y. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 2006;35(1):110-15
167. Basu NK, Kole L, Basu M, et al. Targeted inhibition of glucuronidation markedly improves drug efficacy in a mice model. Biochem Biophys Res Commun 2007;360:7-13
168. Fuchikami H, Satoh H, Tsujimoto M, et al. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 2006;34:577-82
169. Gurley BJ, Swain A, Williams DK, et al. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. Mol Nutr Food Res 2008;52(7):772-9 •• In vivo studies to investigate significance of P-gp-mediated interactions.
170. Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004;75(1):89-100
171. Jan WC, Lin LC, Chen CF, Tsai TH. Herb-drug interaction of Evodia rutaecarpa extract on the pharmacokinetics of theophylline in rats. J Ethnopharmacol 2005;102:440-5
172. Fan L, Mao X-Q, Tao G-Y, et al. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica 2009;39(3):249-54
173. Fan L, Tao G-Y, Wang G, et al. Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers. Ann Pharmacother 2009;43:944-9
174. Markowitz JS, Donovan JL, DeVane CL, et al. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 2003;23(6):576-81
175. Jiang X, Williams KM, Liauw WS, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59(4):425-32
176. Yoshioka M, Ohnishi N, Koishi T, et al. Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of Ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers. Biol Pharm Bull 2004;27(12):2006-9 (Pubitemid 41701579)
177. Yin OQP, Tomlinson B, Waye MMY, et al. Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 2004;14:841-50
178. Lei H-P, Wang G, Wang L-S, et al. Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and estensive metabolizers. Ann Pharmacother 2009;43:726-31
179. Wang Z, Gorski JC, Hamman MA, et al. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70:317-26
180. Dresser GK, Schwartz UI, Wilkinson GR, Kim RB. Coordinate induction of both cytochrome P450 3A4 and MDR1 by St John's wort in healthy subjects. Clin Pharmacol Therap 2003;73:41-50
181. Schwarz UI, Hanso H, Oertel R, et al. Induction of intestinal P-glycoprotein by St John's wort reduces the oral biovailability of talinolol. Clin Pharmacol Ther 2007;81(5):669-78
182. Laitinen LA, Tammela PS, Galkin A, et al. Effects of extracts of commonly consumed food supplements and food fractions on the permeability of drugs across Caco-2 cell monolayers. Pharm Res 2004;21:1904-16
183. Ullah MF. Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pacific J Cancer Prev 2008;9:1-6
184. Farkas D, Oleson LE, Zhao Y, et al. Pomegranate juice does not impair clearance of oral intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice. J Clin Pharmacol 2007;47:286-94
185. Lacy A, O'Kennedy R. Studies on coumarins and coumarin-related compound to determine their therapeutic role in the treatment of cancer. Curr Pharm des 2004;10:3797-811
186. Usia T, Watabe T, Kadota S, Tezuka Y. Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl ligands of Piper cubeca: mechanism-based inhibition. Life Sci 2005;76:2381-91
187. Bano G, Raina RK, Zutshi U, et al. Effect of piperine on biovailability and pharmacokinetics of propanolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991;41:615-18
188. Pattanaik S, Hota D, Prabhakar S, et al. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res 2006;20:683-6
189. Plouzek CA, Ciolino HP, Clarke R, Yeh GC. Inhibition of P-glycoprotein and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer 1999;35:1541-5
190. Nabekura T, Yamaki T, Hiroi T, et al. Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. Pharmacol Res 2010;61:259-63
191. Markowitz JS, Von Moltke LL, Donovan JL. Predicting interactions between conventional medications and botanical products on the basis of in vitro investigations. Mol Nutr Food Res 2008;52:747-63 • One of few studies indicating in vitro/in vivo correlations of herb-drug interactions.
192. El Mastry EM, Abou-Donia MB. Reversal of P-gycoprotein in Escherichia coli leaky mutant by ascorbic acid. Life Sci 2003;23:981-91
193. Ngo N, Yan Z, Graf TN, et al. Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. Drug Metab Disp 2009;37:514-22
194. Yoshida N, Takani A, Kitazawa H, et al. Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli Fructus. Toxicol Applied Pharmacol 2005;209:167-73
195. Appiah-Opong R, Commandeur JN, Axson C, Vermeulen NP. Interactions between cytochrome P450, gluthathione S-transferases, and Ghananian plants. Food Chem Toxicol 2008;46:3598-603